Trials / Terminated
TerminatedNCT03540160
Study of the Long Term Safety of Serlopitant for the Treatment of Pruritus (Itch)
An Open-Label Long-Term Safety Study of Serlopitant for the Treatment of Pruritus
- Status
- Terminated
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 558 (actual)
- Sponsor
- Vyne Therapeutics Inc. · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Study of the long term safety of serlopitant for the treatment of pruritus in adults.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | 5 mg Serlopitant Tablets | Serlopitant Tablets |
Timeline
- Start date
- 2018-03-15
- Primary completion
- 2020-04-08
- Completion
- 2020-06-17
- First posted
- 2018-05-30
- Last updated
- 2021-05-20
- Results posted
- 2020-11-30
Locations
85 sites across 4 countries: United States, Austria, Germany, Poland
Regulatory
- FDA-regulated drug study
Source: ClinicalTrials.gov record NCT03540160. Inclusion in this directory is not an endorsement.